tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AMLX Stock Latest News

Amylyx announces common stock offering, no amount given
The FlyAmylyx announces common stock offering, no amount given
9d ago
AMLX
Amylyx appoints Dan Monahan as Chief Commercial Officer
PremiumThe Fly
Amylyx appoints Dan Monahan as Chief Commercial Officer
12d ago
AMLX
Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development
PremiumThe Fly
Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development
19d ago
AMLX
Amylyx Partners with Gubra for GLP-1 Antagonist
PremiumCompany Announcements
Amylyx Partners with Gubra for GLP-1 Antagonist
19d ago
8K
AMLX
Amylyx announces design of LUCIDITY clinical trial
PremiumThe Fly
Amylyx announces design of LUCIDITY clinical trial
2M ago
AMLX
Amylyx upgraded to Outperform from Neutral at Baird
PremiumThe FlyAmylyx upgraded to Outperform from Neutral at Baird
2M ago
AMLX
Amylyx price target raised to $12 from $8 at H.C. Wainwright
Premium
The Fly
Amylyx price target raised to $12 from $8 at H.C. Wainwright
2M ago
AMLX
Amylyx Pharmaceuticals Q3 2024 Financial Highlights
Premium
Company Announcements
Amylyx Pharmaceuticals Q3 2024 Financial Highlights
2M ago
AMLX
Amylyx reports Q3 EPS ($1.07), consensus (71c)
PremiumThe Fly
Amylyx reports Q3 EPS ($1.07), consensus (71c)
2M ago
AMLX
Amylyx upgraded to Buy at BofA on ‘underappreciated’ PBH opportunity
PremiumThe Fly
Amylyx upgraded to Buy at BofA on ‘underappreciated’ PBH opportunity
3M ago
AMLX
Amylyx upgraded to Buy from Neutral at BofA
PremiumThe Fly
Amylyx upgraded to Buy from Neutral at BofA
3M ago
AMLX
Amylyx announces HELIOS clinical trial meets primary endpoint
PremiumThe Fly
Amylyx announces HELIOS clinical trial meets primary endpoint
3M ago
AMLX
Amylyx Pharmaceuticals Navigates Shift to Smaller Reporting Status: Impacts on Investor Relations and Stock Volatility
PremiumCompany AnnouncementsAmylyx Pharmaceuticals Navigates Shift to Smaller Reporting Status: Impacts on Investor Relations and Stock Volatility
4M ago
AMLX
Amylyx CFO buys $101.4K in common stock
Premium
The Fly
Amylyx CFO buys $101.4K in common stock
4M ago
AMLX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
MPW
SMR
Amylyx reports Q2 EPS ($1.07), consensus (73c)
PremiumThe Fly
Amylyx reports Q2 EPS ($1.07), consensus (73c)
5M ago
AMLX
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
6M ago
UP
USO
Amylyx price target raised to $4 from $3 at Goldman Sachs
PremiumThe Fly
Amylyx price target raised to $4 from $3 at Goldman Sachs
6M ago
AMLX
Amylyx acquires Phase 3-ready avexitide from Eiger for $35.1M plus
PremiumThe Fly
Amylyx acquires Phase 3-ready avexitide from Eiger for $35.1M plus
6M ago
AMLX
Amylyx price target lowered to $3 from $4 at Mizuho
PremiumThe FlyAmylyx price target lowered to $3 from $4 at Mizuho
8M ago
AMLX
Amylyx reports Q1 EPS ($1.75), consensus (1c)
Premium
The Fly
Amylyx reports Q1 EPS ($1.75), consensus (1c)
8M ago
AMLX
Amylyx price target lowered to $3 from $4 at Baird
Premium
The Fly
Amylyx price target lowered to $3 from $4 at Baird
9M ago
AMLX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >